In this report, we describe novel effects of the neurohormone, TRH, on the expression of selected human hair and epidermal keratins. While selected nuclear receptor hormones are appreciated to regulate specific keratins, very little is known about the neuroendocrine control of human keratin expression. Since preliminary microarray evidence from my lab had suggested that TRH may regulate keratin gene transcription, we have followed these pointers up in a pilot study, using organ cultures of microdissected, female scalp hair follicles and full-thickness human skin.
The current study suggests that TRH is indeed a novel modulator of the expression of human hair and epithelial keratins in situ, thus identifying the neuroendocrine regulation of keratin expression as an exciting new research frontier in skin biology.
Together with the recently identified stimulatory activity of TRH on mitochondrial activity, hair pigmentation and hair growth, the potent keratin expression-modulating effects of TRH revealed here may serve as a basis for novel therapeutic strategies that recruit neurohormones to modulate keratin expression in human skin and appendages.
We thank you for your consideration of our manuscript and look forward to your reply.
Best regards, What does this study add?
• The current study provides evidence that the neuropeptide hormone TRH can act as a novel modulator of the expression of human hair and epithelial keratins in situ, thus identifying the neuroendocrine regulation of keratin expression as an exciting new research frontier in skin biology.
• Together with the recently identified stimulatory activity of TRH on mitochondrial activity, hair pigmentation and hair growth, the potent keratin expression-modulating effects of TRH revealed here may serve as a basis for novel therapeutic strategies that recruit neurohormones to modulate keratin expression in human skin and appendages . 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Methods Microdissected human female scalp hair follicles (HFs) and female scalp skin were treated in serum-free organ culture for 12h -6d with 100ng/ml TRH or vehicle. Both quantitative immunohistomorphometry and RT-qPCR were utilized to assess expression of selected keratins.
Results TRH significantly increased expression of the hair keratins K31 and K32, while that of K85 and K86, and of the epithelial keratins K14 and K17 was reduced.
In the interfollicular epidermis, TRH stimulated expression of K6, K14 and K17, both at the mRNA and protein levels. Stimulation of the same keratins was also evident in the eccrine sweat and sebaceous glands.
Conclusions Selected human hair and epithelial keratins are modulated in situ. This may be relevant to explain hair shaft growth-promoting effects of TRH. Our pilot study suggests that the neuroendocrine controls that regulate the expression of human keratins deserve more systematic exploration and that these may be harnessed therapeutically. 3 little is known on the neuroendocrine modulation of keratin expression in human skin, namely of neuropeptide hormones known to be generated in the skin itself.
Interest in the neuroendocrine control of keratin expression in human skin has been invigorated by recent evidence that the neuropeptide hormone, prolactin, profoundly impacts on the expression of keratins such as K5, K6, K14, K15, K19 and K31 in human hair follicles (HFs). 4 Thyroid stimulating hormone (thyrotropin, TSH) was also found to modulate keratin gene expression in the epidermis and HFs. 5, 6 This was underscored by preliminary gene profiling evidence that another neuropeptide hormone, thyrotropin-releasing hormone (TRH), which is also produced by HFs, may interfere and regulate selected intrafollicularly expressed keratins and keratinassociated proteins. 7 Since TRH is a potent stimulator of human hair growth in situ, 7 and also stimulates hair pigmentation, 8 
Materials and methods
Excess human scalp skin was obtained after written informed consent from 6 healthy females during cosmetic face lift surgery (after the University of Luebeck ethics committee approval), as previously described. 5, 7 HF mRNA extracts from two females were subjected to quantitative real-time PCR (RT-qPCR) for selected hair keratin genes after 12h or 24h treatment with TRH (100ng/ml) or vehicle. For immunohistochemical analysis, isolated HFs from an additional female volunteer were organ cultured for 6 days as described previously, 4, 7 and expression of selected keratins and Msx2 (muscle segment homeobox-like 2), a major transcription factor that regulates hair keratin expression
12
, was studied using the staining protocols described in Table 1 . For RT-qPCR evaluation of epithelial keratins, total RNA was isolated from enzymatically separated human epidermis from an additional female volunteer, after 12h culture with 100ng/ml TRH or vehicle. For immunohistochemical analysis of epidermal keratins, skin from two additional different females was organ cultured for 4d with 100 ng/ml TRH or vehicle.
Results
Treatment with 100 ng/ml TRH for 6d significantly increased in situ the immunostaining intensity of the hair keratins K31 (hair cortex) and of K32 (hair cuticle). In contrast, staining intensity of the hair keratins K85 (precortical hair matrix and cuticle), and K86 (mid-to-upper hair cortex) was reduced by TRH. TRH also decreased staining intensity in situ of the epithelial keratins K14 and K17 in the outer root sheath (ORS) of the female anagen scalp HFs ( Figure 1 , A-F). K31 transcription was decreased while K17 mRNA levels were increased by treatment with 100ng/ml TRH for 12h, as assessed by RT-qPCR ( Figure 1 , G). Since according to our previous TRH microarrays, 7 K31 and K32, which represent the hair cortex and hair cuticle, 13 respectively, were both found to be differentially regulated, and considering the importance of K85 as the earliest keratin expressed in the precortical hair matrix and early cuticle, 13 we also checked their transcription in an additional patient (24h culture period). While mRNA levels of both K32 and K85
were decreased, K31 transcription was unchanged ( Figure 1 , H and Supplementary Table 1 ).
In the epidermis, TRH profoundly increased staining intensity for keratins K14, K6
and K17 after 4d of serum-free organ culture in the presence of 100ng/ml TRH 
Discussion
Our pilot study suggests that TRH is a potent, novel modulator of keratin expression in defined epithelial compartments of human skin. This confirms earlier preliminary gene profiling evidence, 7 and suggests that keratins, namely K14, K17, K31, K32, K85 and K86, are (direct or indirect) targets of TRH regulation. Moreover, this study underscores that human skin and HF organ culture are instructive, clinically relevant 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 becomes clinically important to understand whether such analogs might have an effect on skin, and on possible endocrine interactions between intracutaneous production of neurohormones and external TRH application.
In summary, our pilot study reveals yet another important frontier in the ongoing quest to explore of the hypothalamus-pituitary-thyroid axis equivalent of human Microarray analysis has previously shown that several genes are regulated in organcultured human hair follicles at this time point and dose. 7, 9 The staining pattern of selected keratins precisely corresponds to the previously reported pattern; see Table 1 for details. Table 1 ). In addition, MSX2 expression, a transcription factor important for keratin regulation, 6, 12 was not affected by TRH, both at protein and mRNA levels (Supplementary Table 1) .
Results represent triplicate determinations of samples. Total RNA was pooled from 20
HFs. **P<0.01; mean ±SEM. Statistical analysis was performed by two-tailed and KRT17 in enzymatically dissected epidermal cells after 12h organ culture with TRH (100 ng/ml), showed increased mRNA levels of K6 and K14, but no statistically significant change in K17 mRNA levels (A-C). ***P<0.001; mean ±SEM. PCR amplification was carried out by using the TaqMan primers and probes (Assay IDs: Hs01699178_g1 for K6, Hs00265033_m1 for K14, and Hs00356958_m1 for K17) using the TaqMan Universal PCR Master Mix Protocol (Applied Biosystems). As internal controls, transcripts of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined (Assay ID: Hs99999905_m1 for GAPDH). 22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w Figure 1 . TRH (100 ng/ml) regulates expression of K31 (A), K32 (B), K85 (C), K86 (D), K14 (E) and K17 (F) in microdissected, organ-cultured, normal female scalp skin HFs, after 6d of administration, as documented by immunostaining intensity. Microarray analysis has previously shown that several genes are regulated in organ-cultured human hair follicles at this time point and dose.7,9 The staining pattern of selected keratins precisely corresponds to the previously reported pattern; see Table 1 for details. Staining intensities were measured in defined reference areas by quantitative immunohistomorphometry using ImageJ software (NIH, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/) as previously described. Columns represent means±SEM ; n=15-18 HFs/group. P<0.05 vs. Control, **P<0.01, ***P<0.001; unpaired two-tailed Student's t-test. Table 1 ). In addition, MSX2 expression, a transcription factor important for keratin Figure 2 . TRH (100 ng/ml) upregulates expression of K14 (A, D), K6 (B, E) and K17 (C, F) in several skin compartments, including epidermis (semi-quantitative evaluation using ImageJ), sweat glands and sebaceous glands (visual evaluation). Columns represent means±SEM; n = 2 different experiments. Statistical analysis was performed by two-tailed Student's t-test. Relative mRNA expression of KRT6, KRT14 and KRT17 in enzymatically dissected epidermal cells after 12h organ culture with TRH (100 ng/ml), showed increased mRNA levels of K6 and K14, but no statistically significant change in K17 mRNA levels (A-C). ***P<0.001; mean ±SEM. PCR amplification was carried out by using the TaqMan primers and probes (Assay IDs: Hs01699178_g1 for K6, Hs00265033_m1 for K14, and Hs00356958_m1 for K17) using the TaqMan Universal PCR Master Mix Protocol (Applied Biosystems). As internal controls, transcripts of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined (Assay ID: Hs99999905_m1 for GAPDH). 205x189mm (300 x 300 DPI) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 proteins. In addition, in the current pilot study, only a very limited number of human skin fragments was available for organ culture so that definitive conclusions on how TRH regulates expression of any of these keratins on the gene and protein level in situ should be reserved until independent repeat experiments with tissue from additional patients has been performed (since there is rapid RNA degradation in HF organ cultures, qRT-PCR was performed at 12 or 24 hours). The discrepancy between protein and transcription makes it difficult to draw definitive conclusions on whether TRH up-or downregulates intrafollicular expression of these keratins. However, our data available from this pilot study suggest that these keratins are regulated by TRH.
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